Porton Advanced Solutions
Signal active
Organization
Contact Information
Overview
Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.
About
Industries
Biotechnology, Pharmaceutical, Manufacturing, Therapeutics, Genetics
Founded
2018
Employees
101-250
Headquarters locations
Asia
Social
N/A
Profile Resume
Porton Advanced Solutions headquartered in Asia, operates in the Biotechnology, Pharmaceutical, Manufacturing, Therapeutics, Genetics sector. The company focuses on Biotechnology and has secured $5.7B in funding across 40 round(s). With a team of 101-250 employees, Porton Advanced Solutions is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Porton Advanced Solutions, raised $80.0M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
11
Lead Investors
0
Total Funding Amount
$141.3M
Details
2
Porton Advanced Solutions has raised a total of $141.3M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 61.3M | ||
| 2022 | Early Stage Venture | 80.0M |
Investors
Porton Advanced Solutions is funded by 17 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Porton Advanced Solutions | - | FUNDING ROUND - Porton Advanced Solutions | 80.0M |
| Ruilin Investment | - | FUNDING ROUND - Ruilin Investment | 80.0M |
| Porton Advanced Solutions | - | FUNDING ROUND - Porton Advanced Solutions | 80.0M |
| China Merchants Health | - | FUNDING ROUND - China Merchants Health | 80.0M |
Recent Activity
There is no recent news or activity for this profile.